story of the week
Blood Pressure–Lowering Treatment for the Prevention of Major CVDs in People With and Without Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
Lancet Diabetes Endocrinol 2022 Jul 22;[EPub Ahead of Print], M Nazarzadeh, Z Bidel, D Canoy, E Copland, DA Bennett, A Dehghan, G Davey Smith, RR Holman, M Woodward, A Gupta, AI Adler, M Wamil, N Sattar, WC Cushman, RJ McManus, K Teo, BR Davis, J Chalmers, CJ Pepine, K RahimiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.